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GMC’S 2013 GUIDANCE TO DOCTORS
New GMC guidance takes a major, ethically flawed,
backward step
Ian Roberts co-director, clinical trials unit, and professor of epidemiology1, Brigitte Chaudhry founder2,
Iain Chalmers coordinator 3
1London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK; 2RoadPeace, UK; 3James Lind Initiative, Oxford, UK
Doctors and patients have good reason not to be enamoured
with newGeneral Medical Council (GMC) guidance.1Whereas
the 2006 edition of Good Medical Practice stated that doctors
“must work with colleagues and patients . . . to help resolve
uncertainties about the effects of treatments” (para 14f),2 this
principle and the relevant paragraph have been jettisoned from
the recently published 2013 edition. This is all the more perverse
because the statement has often been referred to approvingly in
articles, presentations, and books written for the public, and
readers of the GMC’s guidance on research are referred to it.
This major, ethically flawed, backward step ignores the fact that
patients have suffered and died unnecessarily because doctors
failed to confront uncertainties about the effects of treatments
and to support the research needed to reduce these.3-5
According to the GMC, good doctors must provide clinical care
only when they are satisfied that the drugs or treatments offered
are likely to serve patients’ needs and are based on the best
available evidence (paras 16a, b). We challenge the moral basis
of the GMC’s injunction to use research evidence without an
accompanying injunction to contribute to its production.Without
a responsibility to contribute to the production of new
knowledge this obligation implies a parasitic dependence on
the work of unspecified others. In thankful contrast, the NHS
makes clear its commitment to research and hasmade innovation
and research a priority.6
The new edition of the GMC’s principal guidance to doctors is
a threat to the best interests of patients. It should be withdrawn
and reissued after appropriate amendment.
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